Antihypertensive Treatment in NIDDM, with Special Reference to Abnormal Albuminuria

  • Mark E. Cooper
  • Paul G. McNally

Abstract

The deleterious effects of systemic blood pressure on glomerular structure were reported more than twenty years ago in a patient with NIDDM and unilateral renal artery stenosis, in which characteristic nodular diabetic glomerulosclerosis was present in the non-ischaemic kidney only [1]. Nevertheless, to date the impact of antihypertensive therapy on renal injury in NIDDM has received little attention even though the cumulative incidence of persistent proteinuria and microalbuminuria in NIDDM subjects is comparable in frequency to IDDM subjects of similar duration [2–5]. The clinical relevance of these figures is reflected by statistics which now show that over 50% of patients entering renal replacement programs have NIDDM [6–8]. Furthermore, in NIDDM the relationship between nephropathy and hypertension is more complex than in IDDM, since hypertension is not necessarily linked to the presence of renal disease, and often precedes the diagnosis of diabetes.

Keywords

Diabetic Nephropathy Antihypertensive Agent Antihypertensive Treatment Renal Artery Stenosis NIDDM Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Berkman J, Rifkin H. Unilateral nodular diabetic glomerulosclerosis (Kimmelstiel-Wilson). Report of a case. Metabolism 1973; 22: 715–722.Google Scholar
  2. 2.
    Ballard DJ, Humphrey LL, Melton JI, Frohnert PP, Chu C, O’Fallon WM, Palumbo PJ. Epidemiology of persistent proteinuria in Type II diabetes mellitus. Population-based study in Rochester, Minnesota. Diabetes 1988; 37: 405–412.PubMedCrossRefGoogle Scholar
  3. 3.
    Kunzelman CL, Pettitt DJ, Bennett PH, Knowler WC. Incidence of nephropathy in Type 2 diabetes mellitus. Am J Epidemiol 1985; 122: 547–548.Google Scholar
  4. 4.
    Ritz E, Hasslacher C, Tschope W. Diabetic Nephropathy — are there differences between Type I and Type II. Miner Electrolyte Metab 1990; 16: 69–72.PubMedGoogle Scholar
  5. 5.
    Gall MA, Rossing P, Skott P, Damsbo P, Vaag A, Bech K, Dejgaard A, Lauritzen M, Lauritzen E, Hougaard P, Beck-Nelson H, Parving HH. Prevalence of micro-and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991; 34: 655–661.PubMedCrossRefGoogle Scholar
  6. 6.
    Grenfell A, Bewick M, Parsons V, Snowden S, Taube D, Watkins PJ. Non-insulin-dependent diabetes and renal replacement therapy. Diabetic Med 1988; 5: 172–176.PubMedCrossRefGoogle Scholar
  7. 7.
    US Renal Data System. 1989 Annual Data Report. Bethesda, Maryland: National Institute of Diabetes and Digestive and Kidney Diseases, 1989.Google Scholar
  8. 8.
    Selby JV, Fitzsimmons SC, Newman JM, Katz PP, Sepe S, Showstack J. The natural history and epidemiology of diabetic nephropathy. JAMA 1990; 263: 1954–1960.PubMedCrossRefGoogle Scholar
  9. 9.
    Stornello M, Valvo EV, Puglia N, Scapellato L. Angiotensin converting enzyme inhibition with a low dose of enalapril in normotensive diabetics with persistent proteinuria. J Hypertension 1988; 6: Suppl. 4: S464–S466.Google Scholar
  10. 10.
    Stornello M, Valvo EV, Scapellato L. Angiotensin converting enzyme inhibition in normotensive type II diabetics with persistent mild proteinuria. J Hypertension 1989; 7: Suppl. 6: S314–S315.Google Scholar
  11. 11.
    Stornello M, Valvo EV, Vasques E, Leone S, Scapellato L. Systemic and renal effects of chronic angiotensin converting enzyme inhibition with captopril in hypertensive diabetic patients. J Hypertension 1989; 7: Suppl. 7: S65–S67.Google Scholar
  12. 12.
    Bakris GL. Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus. Ann Int Med 1990; 112: 707–708.PubMedCrossRefGoogle Scholar
  13. 13.
    Stornello M, Valvo EV, Scapellato L. Hemodynamic, renal, and humoral effects of the calcium entry blocker nicardipine and converting enzyme inhibitor captopril in hypertensive type II diabetic patients with nephropathy. J Cardiovasc Pharmacol 1989; 14: 851–855.PubMedCrossRefGoogle Scholar
  14. 14.
    Demarie BK, Bakris GL. Effects of different calcium antagonists on proteinuria associated with diabetes mellitus. Ann Int Med 1990; 113: 987–988.PubMedCrossRefGoogle Scholar
  15. 15.
    Stornello M, Valvo EV, Scapellato L. Comparative effects of enalapril, atenolol and chlorthalidone on blood pressure and kidney function of diabetic patients affected by arterial hypertension and persistent proteinuria. Nephron 1991; 58: 52–57.PubMedCrossRefGoogle Scholar
  16. 16.
    Valvo EV, Bedogna V, Casagrande P, Antiga L, Zamboni M, Bommartini F, Oldrizzi L, Rugiu C, Maschio G. Captopril in patients with type II diabetes and renal insufficiency: systemic and renal hemodynamic alterations. Am J Med 1988; 85: 344–348.PubMedCrossRefGoogle Scholar
  17. 17.
    Nielsen FS, Rossing P, Gall MA, Skott P, Smidt UM, Parving HH. Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy. Diabetes 1994; 43: 1108–1113.PubMedCrossRefGoogle Scholar
  18. 18.
    Chan JC, Cockram CS, Nicholls MG, Cheung CK, Swaminathan R. Comparison of enalapril and nifedipine in treating non insulin dependent diabetes associated with hypertension: one year analysis. BMJ 1992; 305: 98–105.CrossRefGoogle Scholar
  19. 19.
    Ferder L, Daccordi H, Martello M, Panzalis M and Inserra F. Angiotensin converting enzyme inhibitors versus calcium antagonists in the treatment of diabetic hypertensive patients. Hypertension 1992; 19: II–237–242.CrossRefGoogle Scholar
  20. 20.
    Fogari R, Zoppi A, Pasotti C, Mugellini A, Lusardi P, Lazzari P, Corradi L. Comparative effects of ramipril and nitrendipine on albuminuria in hypertensive patients with non insulin dependent diabetes mellitus and impaired renal function. J Hum Hypertens 1995; 9: 13–15.Google Scholar
  21. 21.
    Liou HH, Huang TP, Campese VM. Effect of long term therapy with captopril on proteinuria and renal function in patients with non insulin dependent diabetes and with non diabetic renal diseases. Nephron 1995; 69: 41–48.PubMedCrossRefGoogle Scholar
  22. 22.
    Slataper R, Vicknair N, Sadler R, Bakris GL. Comparative effects of different antihypertensive treatments on progression of diabetic renal disease. Arch Intern Med 1993; 153: 973–980.PubMedCrossRefGoogle Scholar
  23. 23.
    Bakris GL, Barnhill BW, Sadler R. Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection. Kidney Int 1992; 41: 912–919.PubMedCrossRefGoogle Scholar
  24. 24.
    Gambardella S, Frontoni S, Felici MG, Spallone V, Gargiulo P, Morano S, Menzinger G. Efficacy of antihypertensive treatment with indapamide in patients with non-insulin-dependent diabetes and persistent microalbuminuria. Am J Cardiol 1990; 65: 46H–50H.PubMedCrossRefGoogle Scholar
  25. 25.
    Gambardella S, Frontoni S, Lala A, Felici MG, Spallone V, Scoppola A, Jacoangeli F, Menzinger G. Regression of microalbuminuria in type II diabetic, hypertensive patients after long-term indapamide treatment. Am Heart J 1991; 122: 1232–1238.PubMedCrossRefGoogle Scholar
  26. 26.
    Lacourcière Y, Nadeau A, Poirier L, Tancrède G. Captopril or conventional therapy in hypertensive type II diabetics. Three year analysis. Hypertension 1993; 21: 786–794.Google Scholar
  27. 27.
    Flack JR, Molyneaux L, Willey K, Yue DK. Regression of microalbuminuria: results of a controlled study, indapamide versus captopril. J Cardiovasc Pharmacol 1993; 22: Suppl 6: S75–S77.PubMedGoogle Scholar
  28. 28.
    Trevisan R and Tiengo A for the North-East Italy Microalbuminuria Study Group. Effect of low-dose ramipril on microalbuminuria in normotensive or mild hypertensive non-insulin dependent patients. Am J Hypertens 1995; 8: 876–883.PubMedCrossRefGoogle Scholar
  29. 29.
    Sano T, Kawamura T, Matsumae H, Sasaki H, Nakayama M, Hara T, Matsuo S, Hotta N, Sakamoto N. Effects of long term enalapril treatment on persistent micro albuminuria in well controlled hypertensive and normotensive NIDDM patients. Diabetes Care 1994; 17: 420–424.PubMedCrossRefGoogle Scholar
  30. 30.
    Baba T, Tomiyama T, Murabayashi S, Takebe K. Renal effects of nicardipine, a calcium antagonist, in hypertensive Type 2 (non-insulin-dependent) diabetic patients with and without nephropathy. Eur J Clin Pharmacol 1990; 38: 425–429.PubMedCrossRefGoogle Scholar
  31. 31.
    Melbourne Diabetic Nephropathy Study Group. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. BMJ 1991; 302: 210–216.CrossRefGoogle Scholar
  32. 32.
    Romero R, Salinas I, Lucas A, Abad E, Reverter JL, Johnston S, Sanmarti A. Renal function changes in microalbuminuric normotensive type II diabetic patients treated with angiotensin-converting enzyme inhibitors. Diabetes Care 1993; 16: 597–600.PubMedCrossRefGoogle Scholar
  33. 33.
    Cooper ME and Doyle AE. The management of diabetic proteinuria. Which antihypertensive agent? Drugs & Aging 1992; 2: 301–309.CrossRefGoogle Scholar
  34. 34.
    Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Int Med 1993; 118: 577–581.PubMedCrossRefGoogle Scholar
  35. 35.
    Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U et al. Microalbuminuria predicts mortality in non-insulin dependent diabetics. Diabetic Med 1984; 1: 17–19.PubMedCrossRefGoogle Scholar
  36. 36.
    Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N Engl J Med 1984; 310: 356–360.PubMedCrossRefGoogle Scholar
  37. 37.
    Garber A, Vinik A, Crespin S. Detection and management of lipid disorders in diabetic patients. Diabetes Care 1992; 15: 1068–1074.PubMedGoogle Scholar
  38. 38.
    Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 1989; 321: 868–873.PubMedCrossRefGoogle Scholar
  39. 39.
    Pollare T, Lithell H, Selinus I, Berne C. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. BMJ 1989; 298: 1152–1157.PubMedCrossRefGoogle Scholar
  40. 40.
    Harper R, Ennis CN, Heaney AP, Sheridan B, Gormley M, Atkinson AB, Johnston GD, Bell PM. A comparison of the effects of low-and conventional-dose thiazide diuretic on insulin action in hypertensive patients with NIDDM. Diabetologia 1995; 38: 853–859.PubMedCrossRefGoogle Scholar
  41. 41.
    Giordano M, Matsuda M, Sanders L, Canessa ML, DeFronzo RA. Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and «-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension. Diabetes 1995; 44: 665–671.PubMedCrossRefGoogle Scholar
  42. 42.
    Stein P, Black H. Drug treatment of hypertension in patients with diabetes mellitus. Diabetes Care 1991; 14: 425–448.PubMedCrossRefGoogle Scholar
  43. 43.
    Mathiesen ER, Hommel E, Giese J, Parving HH. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ 1991; 303: 81–87.PubMedCrossRefGoogle Scholar
  44. 44.
    Walker WG, Hermann J, Anderson J, Zachary J, Russell RP. Blood pressure (BP) control slows decline in glomerular filtration rate (GFR) in hypertensive NIDDM patients (Abstract). J Am Soc Nephrol 1992; 3: 339.Google Scholar
  45. 45.
    Lebovitz HE, Cnaan A, Wiegmann TB, Broadstone V, Schwartz SL, Sica D, Mengel MC, Versaggi J, Shahinfar S, Bolten WK. Enalapril slows the progression of renal disease in non-insulin-dependent diabetes mellitus (NIDDM): results of a 3-yr multicenter, randomized, prospective, double-blinded study (Abstract). J Am Soc Nephrol 1992; 3: 335.Google Scholar
  46. 46.
    Kasiske BL, Kalil RSN, Ma JZ, Liao M, Keane WF. Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis. Ann Int Med 1993; 118: 129–138.PubMedCrossRefGoogle Scholar
  47. 47.
    Bohlen L, de Courten M, Weidmann P. Comparative study of the effect of ACE inhibitors and other antihypertensive agents on proteinuria in diabetic patients. Am J Hypertens 1994; 7: 84S–92S.PubMedGoogle Scholar
  48. 48.
    Remuzzi G, Bertani T. Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 1990; 38: 384–390.PubMedCrossRefGoogle Scholar
  49. 49.
    Rossing P, Hommel E, Smidt UM, Parving HH. Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients. Diabetes 1993; 42: 715–719.PubMedCrossRefGoogle Scholar
  50. 50.
    Lebovitz HE, Wiegmann TB, Cnaan A, Shahinfar S, Sica DA, Broadstone V, Schwartz SL, Mengel MC, Segal R, Versaggi JA, et al. Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria. Kidney Int 1994; 45: Suppl: S150–S155.CrossRefGoogle Scholar
  51. 51.
    Schnack Ch, Hoffmann W, Hopmeier P, Reinisch W, Schernthaner G. Renal and metabolic effects of one year treatment with ramipril and atenolol in type 2 diabetic patients with microalbuminuria. Diabetologia 1996; in press.Google Scholar
  52. 52.
    Agardh C-D, Carcia-Puig J, Charbonnel B, Angelkort B, Barnett AH. Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine. J Human Hypertens 1996; 10: 185–192.Google Scholar
  53. 53.
    Velussi M, Brocco E, Frigato F, Zolli M, Muollo B, Maioli M, Carraro A, Tonolo G, Fresu P, Cernigoi AM, Fioretto P, Nosadini R. Effects of Cilazapril and Amlodipine on kidney function in hypertensive NIDDM patients. Diabetes 1996; 45: 216–222.PubMedCrossRefGoogle Scholar
  54. 54.
    Ravid M, Lang R, Rachmani R, Lishner M. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study. Arch Intern Med 1996; 156: 286–289.PubMedCrossRefGoogle Scholar
  55. 55.
    Vora JP, Leese GP, Peters JR, Owens DR. Longitudinal evaluation of renal function in non-insulin-dependent diabetic patients with early nephropathy: Effects of angiotensin-converting enzyme inhibition. J Diabetes and Its Complications 1996; 10: 88–93.CrossRefGoogle Scholar
  56. 56.
    Liou H-H, Huan T-P, Campese VM. Effect of long-term therapy with captopril on proteinuria and renal function in patients with non-insulin-dependent diabetes and with non-diabetic renal diseases. Nephron 1995; 69: 41–48.PubMedCrossRefGoogle Scholar
  57. 57.
    Dominguez LJ, Barbagallo M, Kattah W, Carcia D, Sowers JR. Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects. Am J Hypertens 1995; 8: 808–814.PubMedCrossRefGoogle Scholar
  58. 58.
    Nielsen FS, Rossing P, Gall M-A, Skøtt P, Smidt UM, Parving H-H. Long term impact of lisinopril and atenolol on kidney function in NIDDM patients with diabetic nephropathy (Abstract). Diabetologia 1996; 39: Suppl. 1: A307.Google Scholar
  59. 59.
    Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M. Intensive inulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995; 28: 103–117.PubMedCrossRefGoogle Scholar

References

  1. 1.
    Shapiro AP, Perez-Stable E, Moutsos SE. Co-existence of renal arterial hypertension and diabetes mellitus. JAMA 1965; 192: 813–816.PubMedCrossRefGoogle Scholar
  2. 2.
    Munichoodappa C, D’Elia JA, Libertino JA, Gleason RE, Christlieb R. Renal artery stenosis in hypertensive diabetics. J Urol 1979; 121: 555–558.PubMedGoogle Scholar
  3. 3.
    Ritchie CM, Mcllrath E, Hadden DR, Weaver JA, Kennedy L, Atkinson AB. Renal artery stenosis in hypertensive diabetic patients. Diabetic Med 1988; 5: 165–267.Google Scholar
  4. 4.
    Svetkey LP, Himmelstein SI, Dunnick NR, et al. Prospective analysis of strategies for diagnosing renovascular hypertension. Hypertension 1989; 14: 247–257.PubMedCrossRefGoogle Scholar
  5. 5.
    Sawicki PT, Heinemann L, Frenzel H, Berger M. Prevalence of renal artery stenosis in diabetes mellitus — and autopsy study. J Intern Med 1991; 229: 489–492.PubMedCrossRefGoogle Scholar
  6. 6.
    Robinson ACJ, Kong C, Henzen C, Pacy P, Chong P, Gedroyc W, Elkeles RS, Robinson S. Magnetic resonance angiography and renal artery stenosis in hypertensive patients with type 2 diabetes (Abstract). Diabetologia 1996; 39: Suppl. 1: A36.Google Scholar
  7. 7.
    Zucchelli P, Zuccala A. »Ischaemic nephropathy.« In Oxford Textbook of Clinical Nephrology, 1996; in press.Google Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • Mark E. Cooper
    • 1
    • 2
  • Paul G. McNally
    • 1
    • 2
  1. 1.Department of MedicineUniversity of Melbourne, Austin & Repatriation Medical CentreWest HeidelbergAustralia
  2. 2.Leicester Royal Infirmary NHS TrustLeicesterUnited Kingdom

Personalised recommendations